International Patent: COMPOSITIONS FOR CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY IN THE TREATMENT OF SEMAPHORIN 7A POSITIVE HEALTH CONDITIONS

GENEVA, Sept. 24 -- THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE filed a patent application (US2026/019676) for “COMPOSITIONS FOR CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY IN THE TREATMENT OF SEMAPHORIN 7A POSITIVE HEALTH CONDITIONS”. With publication no. WO/2026/198622, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 39/395

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....